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CURRENT STATUS OF LIVER 
TRANSPLANTATION 
Liver replacement with a homograft (orthotopic liver 
transplantation) was first attempted in a human on 
March 1, 1963.1 Since then more than a hundred pa-
tients have been treated with this procedure at the 
University of Colorado. More than a hundred addi· 
tional cases have been accumulated in other centers. 
The second most active group in the field has been 
composed of personnel at Addenbrooke Hospital, 
Cambridge, and at King's College Hospital, London. 
The British inter-university effort has involved the 
fruitful collaboration of the surgeon, Professor Roy 
Caine, and the gastroenterologist, Professor. Roger 
Williams, and has resulted in approximately 50 ortho-
topic liver transplantations. 
In the 13 years of our own experience, the most 
meaningful conclusion has been that prolonged sur-
vival was repeatedly possible.2 Among our first 100 
recipients, 28 lived at least one postoperative year, 15 
are still alive, and the longest follow-up is now 6.6 
years. This last patient was a 3-year-old, child with 
biliary atresia. Three other recipients in our series have 
lived more than five years after transplantation, two for 
Wilson's disease and another for biliary atresia. 
Most of the long-term survivors, particularly those 
in the last several years, have had stable liver function 
and thus have been able to achieve social and voca-
tional rehabili tation equal to that of kidney homograft 
recipients.2 Long-term survival after liver transplanta-
tion has also been achieved by teams at Cambridge-
King's College, Commonwealth of Virginia, University 
of Montreal, and New York Memorial Hospital. 
Conceding that the feasibility stage of liver trans-
plantation has long been passed, the important issues 
now being examined are the reasons why the one-year 
mortality has remained high and how this situation 
can be improved. One explanation is that the operation 
can be extraordinarily difficult. In children we have 
encountered a very high incidence of technical com-
plications including homograft ischemic necrosis, graft 
vascular thrombosis, uncontrolled hemorrhage, and, 
above all, biliary duct complications.3 All of these 
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misadventures, except for biliary duct problems, tend 
to cause death within the first few days after operation. 
Liver transplantation in adults can be even more 
formidable because of the nearly uncontrollable hemor-
rhage caused by a combination of deficient clotting 
factors and severe portal hypertension, which arises 
during operation in patients with end-stage liver 
disease. Adults, no less than children, have suffered a 
high mortality from biliary fistulas and obstructions. 
Finally, irreversible brain injury during or just after 
operation has coSt the life of about one fifth of our 
adult recipients. Our suspicion is that much of the 
difficulty was caused by air entrapped in the graft 
which then embolized in tiny bubbles through the 
pulmonary bed into the systemic circulation. 
As the foregoing technical and management prob-
lems have become better defined, preventive measures 
have evolved. The use of microsurgical technics has 
reduced vascular problems in pediatric recipients. 
Biliary reconstruction and the treatment of biliary 
complications have greatly improved in the last two or 
three years. The threat of air embolism can be marked I y 
reduced by slowly perfusing the homograft portal vein 
with an electrolyte solution during performance of the 
vascular anastomoses, thus filling the vascular tree. 
Correction of these various faults should lead to a 
favored position of the liver among organ grafts. In 
rats, dogs, and pigs, the liver is not as vigorously rejected 
as the kidney and other tissues. Rejection has been an 
uncommon feature in the livers examined at autopsies 
of our unsuccessfully treated liver recipients.2 Far more 
commonly, serious mechanical imperfections have been 
found. 
As progress of the kind already described continues, 
liver transplantation will be more freely applied at an 
earlier time. We presently believe recipients should be 
young, 45 years or less. The ideal indication for liver 
replacement is otherwise untreatable, chronic, non-
neoplastic hepatic disease, such as biliary atresia or 
chronic aggressive hepatitis. Although our experience 
has been poor in Laennec's cirrhosis, the inferior results 
probably reflect, for the most part, excessively late 
consideration of transplantation. Inborn errors of 
metabolism so far "cured" by liver replacement include 
Wilson's disease, alphal-antitrypsin deficiency, 
Niemann-Pick disease, and tyrosinemia. 
The role ofliver transplantation for primary hepatic 
malignancy will have to be clarified in future trials. It 
is clear that a very high rate of recurrence can be ex-
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pee ted in hepatomas, cholangiocarcinomas, intrahepatic 
duct cell carcinomas, and less common malignant 
neoplasms. Yet, we now have two patients living, one 
after two years and the other after six years, following 
whole liver resection for an intrahepatic duct cell 
carcinoma and for a hepatoma, respectively. 
At the moment, liver transplantation remains experi-
mental, but with the proviso that many patients have 
benefited from the procedure. There is little reason to 
doubt that hepatic replacement will be a more common 
operation in the years to come. A shortage of organs 
may then present an obstacle, as has occurred with the 
kidney. The resulting logistic problems of organ storage 
and shipment are solvable, however. Using simple in-
fusion with cold Collins' solution, we recently removed 
a liver in Los Angeles, carried it to Denver on a com-
mercial airliner, and successfully transplanted it after 
an ischemic period of seven hours. 
Thomas E. Starzl, MD 
Charles W. Putnam, MD 
Lawrence J. Koep, MD 
Department of Surgery 
University of Colorado Medical Center 
4200 E Ninth Ave 
Denver, Colo 80262 
References 
1. Starzl TE. Putnam C\V: Experience in Hepatic Transplantation. 
Philadelphia, W.B. Saunders Co., 1969 
2. Starzl TE, Porter KA, Putnam CW, et al: Orthotopic liver transplanta-
tion in 93 patients. Surg Gynecol lh~tiDl 142:487-505, 1976 
3. Startl TE, Porter KA, Putnam C\V, ct al: Biliary complication~ afler 
liver transplantation: \\.:ith special reference to the hiliar) cast syndrome 
and techniques of secondary duct repair. Surgery (In press) 
390 April1977. SOUTHERN MEDICAL JOURNAL • Vol 70, NO.4 
